Do you speak Italian and enjoy teaching? Share your language skills with children and teenagers during the upcoming school year. Do you have experience preparing students for official language exams and want to help them achieve
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)